The National Cardiovascular Data Registry PINNACLE (Practice Innovation and Clinical Excellence) Registry is the largest outpatient cardiovascular practice registry in the world. It tracks real-world management and quality of 4 common cardiovascular conditions: heart failure, coronary artery disease, atrial fibrillation, and hypertension. In 2013, the PINNACLE Registry contained information on 2,898,505 patients, cared for by 4,859 providers in 431 practices. By 2017, the registry contained information on 6,040,996 patients, cared for by 8,853 providers in 724 practices. During this time period, care processes for PINNACLE patients generally improved. Among patients with heart failure, combined beta-blocker and renin-angiotensin antagonist medication rates increased from 60.7% to 72.8%. Among patients with coronary artery disease, statin medication rates increased from 66% to 80.1%. Among patients with atrial fibrillation, oral anticoagulation rates increased from 52.7% to 65.2%. In contrast, blood pressure control rates among patients with hypertension were largely stable. PINNACLE data also fueled a variety of quality measurement programs and 51 peer-reviewed publications.

中文翻译：

---

2013 年至 2017 年美国门诊心血管护理的趋势

国家心血管数据登记处 PINNACLE（实践创新和临床卓越）登记处是世界上最大的门诊心血管实践登记处。它跟踪 4 种常见心血管疾病的实际管理和质量：心力衰竭、冠状动脉疾病、心房颤动和高血压。2013 年，PINNACLE Registry 包含 2,898,505 名患者的信息，由 4,859 名提供者在 431 家诊所提供护理。到 2017 年，登记处包含 6,040,996 名患者的信息，由 724 家诊所的 8,853 名提供者提供护理。在此期间，PINNACLE 患者的护理流程普遍得到改善。在心力衰竭患者中，β-受体阻滞剂和肾素-血管紧张素拮抗剂联合用药率从 60.7% 增加到 72.8%。在冠心病患者中，他汀类药物的用药率从 66% 增加到 80.1%。在房颤患者中，口服抗凝剂的使用率从 52.7% 增加到 65.2%。相比之下，高血压患者的血压控制率基本稳定。PINNACLE 数据还推动了各种质量测量计划和 51 份同行评审的出版物。